Bo Kruse - May 30, 2024 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
EVP, CFO, SECRY & TREAS.
Signature
/s/ John LaRocca, Attorney-in-Fact
Stock symbol
YMAB
Transactions as of
May 30, 2024
Transactions value $
-$603,055
Form type
4
Date filed
5/31/2024, 09:36 PM
Previous filing
Jan 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Options Exercise $57.3K +28.6K +13.58% $2.00 240K May 30, 2024 Direct
transaction YMAB Common Stock Sale -$344K -28.6K -11.95% $12.03 211K May 30, 2024 Direct F1
transaction YMAB Common Stock Options Exercise $62.7K +31.4K +14.88% $2.00 242K May 31, 2024 Direct
transaction YMAB Common Stock Sale -$379K -31.4K -12.95% $12.07 211K May 31, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YMAB Employee Stock Option (right to buy) Options Exercise $0 -28.6K -9.54% $0.00 271K May 30, 2024 Common Stock 28.6K $2.00 Direct F3
transaction YMAB Employee Stock Option (right to buy) Options Exercise $0 -31.4K -11.56% $0.00 240K May 31, 2024 Common Stock 31.4K $2.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $11.85 to $12.22, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $11.87 to $12.42, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 All of these stock options are currently vested.